Posts in the “Clinical Trials Clinical Trials” category:

Lung-MAP trial launched, matching patients to treatments based on tumor profiles

Posted by Samantha Powell on June 16th, 2014 |

A phase II/III trial using genomic profiling to match patients with investigational treatments began recruiting patients with advanced squamous cell lung cancer on June 16, 2014. The Lung-MAP (Lung Cancer Master Protocol) trial is a public-private collaboration among the National Cancer Institute (NCI), SWOG Cancer Research, Friends of Cancer Research, the Foundation for the National […]

Bonnie J. Addario Lung Cancer Foundation Joins Lung-MAP, Collaborative Group Multi-drug, Biomarker-driven Clinical Trial for Lung Cancer

Posted by Samantha Powell on June 16th, 2014 |

For further information or inquiries, please contact: Matt Notley Perry Communications matt@perrycom.com Bonnie J. Addario Lung Cancer Foundation Joins Lung-MAP, Collaborative Group Multi-drug, Biomarker-driven Clinical Trial for Lung Cancer Innovative approach to clinical testing to improve access and ease burden on researchers SAN CARLOS, CA (May 19, 2014) — The Bonnie J Addario Lung Cancer […]

Researchers Deliver Double Dose of Lung Cancer Discoveries

Posted by Samantha Powell on June 4th, 2014 |

Researchers at UCLA’s Jonsson Comprehensive Cancer Center (JCCC) are reporting exciting dual discoveries in the treatment of non-small-cell lung cancer (NSCLC), which accounts for about 85 percent of all lung cancers, the leading cause of cancer deaths in the United States. Two new experimental drugs, ramucirumab and CO-1868, developed for use in patients with advanced […]

Genprex Begins Phase 2 Lung Cancer Trial

Posted by Samantha Powell on May 20th, 2014 |

Date: 5/20/14 Outlet Full Name: Drug Discovery and Development Author: No author http://www.dddmag.com/news/2014/05/genprex-begins-phase-2-lung-cancer-trial Genprex Inc. announced that it has enrolled the first patient in a clinical trial evaluating its lead product candidate Oncoprex in combination with erlotinib (Tarceva) for late-stage lung cancer patients. Oncoprex is a targeted biologic incorporating the pan-kinase inhibitor TUSC2, which inhibits […]

New Video Delves Into the Promise of Lung Cancer Immunotherapy Clinical Trials for Patients With Non-Small Cell Lung Cancer

Posted by Samantha Powell on May 15th, 2014 |

Date: 5/15/14 Outlet Full Name: Digital Journal Author: No author http://www.digitaljournal.com/pr/1922309 A recently released video on cancer immunotherapy is offering new hope to patients with non-small cell lung cancer (NSCLC), the type of cancer which makes up 85% to 90% of all lung cancer cases in the US and claims more lives each year than […]

AstraZeneca Starts Phase III Immunotherapy Study for MEDI4736 in Patients With Lung Cancer

Posted by Samantha Powell on May 8th, 2014 |

News Headline: AstraZeneca Starts Phase III Immunotherapy Study for MEDI4736 in Patients With Lung Cancer Date: 5/8/14 Outlet Full Name: Pharmaceutical Processing Author: No author http://www.pharmpro.com/news/2014/05/astrazeneca-starts-phase-iii-immunotherapy-study-medi4736-patients-lung-cancer AstraZeneca today announced the start of the Phase III program for MEDI4736, an immunotherapy in development for the treatment of non-small cell lung cancer (NSCLC) and other cancers. The […]

A Lung Cancer Trial Success Story

Posted by Samantha Powell on April 22nd, 2014 |

News Headline: A Lung Cancer Trial Success Story Date: 4/22/14 Outlet Full Name: About.com Author: Lynne Eldridge http://lungcancer.about.com/b/2014/04/22/a-lung-cancer-clinical-trial-success-story.htm I’ve often written about the pro’s and con’s of clinical trials. On the positive side, the only way we make progress in treating cancer is through evaluating medications and other treatments in clinical trials. On the other […]

Phase III Immunotherapy Lung Cancer Trial Stopped Early

Posted by Samantha Powell on April 18th, 2014 |

Date: 4/18/14 Outlet Full Name: Cancer Network Author: Dave Levitan http://www.cancernetwork.com/lung-cancer/phase-iii-immunotherapy-lung-cancer-trial-stopped-early GlaxoSmithKline has stopped a phase III trial of a novel lung cancer immunotherapeutic agent, after determining that it may not be possible to identify which genetic subgroups may benefit from the treatment. Vincent Brichard, the senior vice-president and head of immunotherapeutics at the company […]

New Kind of Trial Aims to Speed Cancer Drug Development

Posted by Samantha Powell on April 16th, 2014 |

Date: 4/16/14 Outlet Full Name: Reuters Author: Ben Hirschler http://www.reuters.com/article/2014/04/16/us-cancer-trials-idUSBREA3F22520140416 Scientists and drugmakers are pioneering a new kind of clinical trial that changes the way cancer drugs are studied, potentially cutting both the time and cost of bringing them to market. Instead of testing one drug at a time, a novel lung cancer study announced […]

GlaxoSmithKline Throws in Towel on Lung Cancer Vaccine Trial

Posted by Samantha Powell on April 2nd, 2014 |

Date: 4/2/14 Outlet Full Name: Reuters Author: Ben Hirschler http://www.reuters.com/article/2014/04/02/us-gsk-cancer-idUSBREA310E420140402 GlaxoSmithKline Plc (GSK) has stopped a high-profile clinical trial using a novel vaccine to fight lung cancer after deciding it will not be possible to find a sub-group of patients who might benefit. The decision comes less than two weeks after GSK said the MAGE-A3 […]